scispace - formally typeset
M

Martina Ulrich

Researcher at University of Tübingen

Publications -  31
Citations -  4151

Martina Ulrich is an academic researcher from University of Tübingen. The author has contributed to research in topics: Cystic fibrosis & Staphylococcus aureus. The author has an hindex of 21, co-authored 31 publications receiving 3893 citations.

Papers
More filters
Journal ArticleDOI

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

TL;DR: In CF patients with established lung disease, Pseudomonas aeruginosa was located within hypoxic mucopurulent masses in airway lumens, and in vitro studies revealed that CF-specific increases in epithelial O(2) consumption, linked to increased airway surface liquid (ASL) volume absorption and mucus stasis, generated steep hypoxic gradients within thickened mucus on CF epithelial surfaces prior to infection.
Journal ArticleDOI

Broadly Protective Vaccine for Staphylococcus aureus Based on an in Vivo-Expressed Antigen

TL;DR: PNSG is a candidate for use in a vaccine to protect against S. aureus infection and protected mice against kidney infections and death from strains that produced little PNSG in vitro.
Journal ArticleDOI

Anaerobic Conditions Induce Expression of Polysaccharide Intercellular Adhesin in Staphylococcus aureus and Staphylococcus epidermidis

TL;DR: It is demonstrated that anaerobic in vitro growth conditions lead to increased polysaccharide expression in both S. aureus and S. epidermidis, which suggests a mechanism whereby ica gene expression and poly Saccharide production may act as a virulence factor in an an aerobic environment in vivo.
Journal ArticleDOI

Colistin-Tobramycin Combinations Are Superior to Monotherapy Concerning the Killing of Biofilm Pseudomonas aeruginosa

TL;DR: Colistin-tobramycin combinations are more efficient than respective single antibiotics for killing P. aeruginosa in biofilms in vitro, and they significantly reduced P.aerug inosa cell counts in a rat lung infection model and in patients with cystic fibrosis.